Congress Is Asking Why The Price Of A Life-Saving Drug Is Skyrocketing
The cost of a pair of EpiPens has risen by as much as 900 percent.By Ryan Biek | August 23, 2016
Congress is questioning the company that makes a life-saving drug over its skyrocketing price.
The EpiPen has a virtual monopoly in both business and effectiveness. Some argue there are no real alternative besides the EpiPen in the case of a serious allergic reaction. When these reactions do happen, a shot from an EpiPen can open airways, slow heart rates and reverse drops in blood pressure.
Since pharmaceutical company Mylan got the rights to the product in 2007, the price has increased by as much as 900 percent.